<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> also called spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>) is a hereditary and neurodegenerative <z:hpo ids='HP_0100022'>movement disorder</z:hpo> caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002529'>Neuronal loss</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> is associated with a mutant ataxin-3 toxic fragment </plain></SENT>
<SENT sid="2" pm="."><plain>Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s) </plain></SENT>
<SENT sid="3" pm="."><plain>Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained <z:chebi fb="0" ids="53000">epitopes</z:chebi> C-terminal to amino acid 220 </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we generated and characterized <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71) </plain></SENT>
<SENT sid="5" pm="."><plain>Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model </plain></SENT>
<SENT sid="6" pm="."><plain>The transgenic mice developed an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>-like phenotype and their brain homogenates had a fragment containing <z:chebi fb="0" ids="53000">epitopes</z:chebi> C-terminal to amino acid 220 </plain></SENT>
<SENT sid="7" pm="."><plain>Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190 </plain></SENT>
</text></document>